British Patient Capital Commits £25m to Dementia Discovery Fund 2
Funding | Mar 20, 2025 | British Business Bank Investments Ltd
British Patient Capital, a subsidiary of the British Business Bank, has pledged £25 million to SV Health Investors’ Dementia Discovery Fund 2 (DDF-2), aiming at pioneering therapeutics for dementia. This follows a previous £24 million investment in the inaugural Dementia Discovery Fund. Operating as a specialized venture capital fund, DDF focuses exclusively on innovative treatments for dementia, a critical global health issue. With expertise in neuroscience and strong ties to academia and industry, the fund has backed 19 promising companies since 2015, resulting in significant clinical advancements, follow-on investments, and strategic partnerships. The inclusion of British Patient Capital's investment completes DDF-2's $250 million fundraising goal. Over the last decade, advancements in neurodegenerative research have paralleled the introduction of the first disease-modifying treatments for dementia. This fund aims to leverage these developments to advance first-in-class therapeutics.
Sectors
- Biotechnology
- Venture Capital
- Healthcare
Geography
- United Kingdom – British Patient Capital, part of the British Business Bank, is based in the UK.
- Global – The Dementia Discovery Fund seeks global academic partnerships and strategic alliances.
Industry
- Biotechnology – The article focuses on funding for dementia therapeutics, a key segment in the biotechnology industry.
- Venture Capital – The investment by British Patient Capital into the Dementia Discovery Fund 2 highlights the role of venture capital in advancing medical treatments.
- Healthcare – With a focus on dementia, a significant health challenge, the article aligns with the healthcare sector.
Financials
- £25 million – The amount committed by British Patient Capital to the Dementia Discovery Fund 2.
- $250 million – The target fundraising amount achieved by the Dementia Discovery Fund 2.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| British Patient Capital | Investor | Company | A commercial subsidiary of the British Business Bank investing in the Dementia Discovery Fund 2. |
| British Business Bank | Parent Company | Company | The parent company of British Patient Capital. |
| Dementia Discovery Fund | Target Fund | Company | A specialized venture capital fund focused on dementia therapeutics. |
| SV Health Investors | Fund Manager | Company | Manages the Dementia Discovery Fund 2. |
| Christian Jung | Partner | Person | Partner at SV Health Investors contributing to the investment strategy. |